Company intelligence / Profile preview
HippoFi
Irvine, California, United Stateshippofi.com ↗
- Ownership
- Private
- Development stage
- Commercial
01
Overview
HippoFi has commercialized several advanced biomaterials for spinal fusion and orthopedic procedures through its subsidiary PUR Biologics. The company has FDA 510(k) clearance for some products such as ActiveOrbTM. It is also developing next-generation regenerative stem cell and growth factor-driven therapeutics targeting osteoarthritis and cartilage regeneration. Clinical results have not been published but the company reports strong sales growth with adoption at major healthcare facilities
- Therapeutic areas
- Rheumatology
- Modalities
- AllograftDemineralized extracellular matrixSynthetic bone-forming solutionCellular-derived tissue therapyStem cell therapyGrowth factor-driven therapeutics
- Industry
- Biotech
02
Drug pipeline
1 asset03
Partnerships
Zimmer Biomet – exclusive global license to underlying synthetic biomaterial technology for spine market; joint commercialization agreement with Zimmer overseeing production under the PUR brandBPB Medica – exclusive partnership to launch surgical device "PURmarrow360" in US marketHoag Hospital Newport Beach – clinical collaboration partner mentioned among key alliancesPrecision Spine – industry alliance
Beyond the preview
Go deeper on HippoFi.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on HippoFi.